Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Douglas A. Fisher is active.

Publication


Featured researches published by Douglas A. Fisher.


Acta Crystallographica Section D-biological Crystallography | 2009

New Kinase Regulation Mechanism Found in HipBA: a Bacterial Persistence Switch

Artem G. Evdokimov; Igor Voznesensky; Kimberly F. Fennell; Marie Anderson; James F. Smith; Douglas A. Fisher

Bacterial persistence is the ability of individual cells to randomly enter a period of dormancy during which the cells are protected against antibiotics. In Escherichia coli, persistence is regulated by the activity of a protein kinase HipA and its DNA-binding partner HipB, which is a strong inhibitor of both HipA activity and hip operon transcription. The crystal structure of the HipBA complex was solved by application of the SAD technique to a mercury derivative. In this article, the fortuitous and interesting effect of mercury soaks on the native HipBA crystals is discussed as well as the intriguing tryptophan-binding pocket found on the HipA surface. A HipA-regulation model is also proposed that is consistent with the available structural and biochemical data.


Journal of Biomolecular Screening | 2007

A nuclear magnetic resonance-based functional assay for nicotinamide adenine dinucleotide synthetase.

Brian J. Stockman; Ian J. Lodovice; Douglas A. Fisher; Alexander S. McColl; Zhi Xie

Nicotinamide adenine dinucleotide synthetase (NadE) is an essential enzyme for bacterial pathogens and is thus a promising antibacterial target. It catalyzes the conversion of nicotinic acid adenine dinucleotide to nicotinamide adenine dinucleotide. Changes in chemical shifts that occur in the nicotinic acid ring as it is converted to nicotinamide can be used for monitoring the reaction. A robust nuclear magnetic resonance—based activity assay was developed using robotically controlled reaction initiation and quenching. The single-enzyme assay has less potential for false positives compared to a coupled activity assay and is especially well suited to the high concentration of compounds in fragment screens. The assay has been used to screen fragment libraries for NadE inhibitors. ( Journal of Biomolecular Screening 2007:457-463)


Science | 2003

Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor

Paul S. Changelian; Mark Edward Flanagan; Douglas J. Ball; Craig R. Kent; Kelly S. Magnuson; William H. Martin; Bonnie J. Rizzuti; Perry S. Sawyer; Bret D. Perry; Sandra P. McCurdy; Elizabeth M. Kudlacz; Maryrose J. Conklyn; Eileen A. Elliott; Erika R. Koslov; Michael B. Fisher; Timothy J. Strelevitz; Kwansik Yoon; David A. Whipple; Jianmin Sun; Michael John Munchhof; John L. Doty; Jeffrey M. Casavant; Todd Andrew Blumenkopf; Michael Hines; Matthew Frank Brown; Brett M. Lillie; Chakrapani Subramanyam; Chang Shang-Poa; Anthony J. Milici; Gretchen E Beckius


Journal of Biological Chemistry | 1998

Isolation and Characterization of PDE9A, a Novel Human cGMP-specific Phosphodiesterase

Douglas A. Fisher; James F. Smith; J.S. Pillar; Suzanne H. St. Denis; John B. Cheng


Biochemical and Biophysical Research Communications | 1998

Isolation and Characterization of PDE8A, a Novel Human cAMP-Specific Phosphodiesterase☆

Douglas A. Fisher; James F. Smith; J.S. Pillar; Suzanne H. St. Denis; John B. Cheng


Journal of Immunology | 1997

Identification of a STAT6 domain required for IL-4-induced activation of transcription.

Binfeng Lu; Martin Reichel; Douglas A. Fisher; James F. Smith; Paul Rothman


Archive | 2002

Novel human phosphodiesterase IV isozymes

Douglas A. Fisher; Michael D. Robbins


Archive | 1995

hPDE IV-C: a novel human phosphodiesterase IV isozyme

Douglas A. Fisher


Bioorganic & Medicinal Chemistry Letters | 2006

A new chemical tool for exploring the role of the PDE4D isozyme in leukocyte function

Robert J. Chambers; Kristin Abrams; Tessa A. Castleberry; John B. Cheng; Douglas A. Fisher; Ajith V. Kamath; Anthony Marfat; David O. Nettleton; Joann D. Pillar; Eben D. Salter; Alissa L. Sheils; John T. Shirley; Claudia R. Turner; John P. Umland; Kelvin Lam


Archive | 1995

Screening novel human phosphodiesterase IV isozymes for compounds which modify their enzymatic activity

Douglas A. Fisher; Michael D. Robbins

Collaboration


Dive into the Douglas A. Fisher's collaboration.

Researchain Logo
Decentralizing Knowledge